American River Nutrition
American River Nutrition has been an evidence-based research leader in the manufacturing of premium annatto-derived dietary ingredients for over two decades.
Manufactured in the USA
American River Nutrition strives to provide the purest form of annatto-derived ingredients by manufacturing everything in our 24,000 square foot facility in Hadley, Massachusetts, using a range of proprietary processes and technologies.
American River Nutrition has been an evidence-based research leader in the manufacturing of premium annatto-derived dietary ingredients for over two decades.
Manufactured in the USA
American River Nutrition strives to provide the purest form of annatto-derived ingredients from our 24,000 square foot facility in Hadley, Massachusetts, using a range of proprietary processes and technologies.
American River Nutrition’s Next Generation Ubiquinol
our products
Annatto-centric innovation is in our DNA. Compelled by research, our products leverage the efficacious compounds of the annatto plant, including DeltaGold® the only tocopherol-free source of tocotrienols, GG-Gold® a building block of healthy aging, and DuoQuinol®, a more functionally active ubiquinol.
Notes from our Team
News & Updates
Tocotrienols May Have Protective Effect on Liver in NAFLD Patients
Hadley, Massachusetts (February 8, 2023) – Delta-tocotrienol from annatto downregulated gene expressions associated with non-alcoholic fatty liver disease in patients. Supplementing with annatto-derived tocotrienols branded as DeltaGold® by American River Nutrition
Annatto Tocotrienol plus Resveratrol may improve cardiometabolic risk in MetS: RCT
Hadley, Massachusetts (December 20, 2022) – A combination of delta-tocotrienol from annatto improved cardiometabolic risk factors, including central obesity and blood pressure, suggest findings from a randomized clinical study. Twenty-four
Delta-tocotrienol upstages alpha-tocopherol in fatty liver disease trial
Hadley, Massachusetts (September 23, 2022) – Supplementation with delta-tocotrienol may edge out the competition in improving biomarkers of non-alcoholic fatty liver disease (NAFLD), says a study conducted at the Armed